R.Adams Dudley, MD, MBA


Pulmonary, Critical Care, Allergy and Sleep Medicine

M.D., 1991 - School of Medicine, Duke University
Honors and Awards
  • Elected to, Association of American Physicians, 2016
  • Elected to, American Society for Clinical Investigation, 2010
  • Investigator Award in Health Policy, Robert Wood Johnson Foundation, 2005
  1. How Influenza Vaccination Rate Variation Could Inform Pandemic-Era Vaccination Efforts.
  2. Predicting NICU admissions in near-term and term infants with low illness acuity.
  3. The Opioid Epidemic Blunted the Mortality Benefit of Medicaid Expansion.
  4. Long-Term Trends in Postoperative Opioid Prescribing, 1994 to 2014.
  5. Long-Term Trends in Postoperative Opioid Prescribing, 1994 to 2014.
  6. How care decisions are made among interdisciplinary providers caring for critically injured patients: A qualitative study.
  7. Age- and Lesion-Related Comorbidity Burden Among US Adults With Congenital Heart Disease: A Population-Based Study.
  8. Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan Under Medicare Part D.
  9. The costs of dementia subtypes to California Medicare fee-for-service, 2015.
  10. Validation of Prediction Models for Critical Care Outcomes Using Natural Language Processing of Electronic Health Record Data.
  11. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs.
  12. Trends in Hospitalization, Readmission, and Diagnostic Testing of Patients Presenting to the Emergency Department With Syncope.
  13. Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D.
  14. Accurate and interpretable intensive care risk adjustment for fused clinical data with generalized additive models.
  15. A Revised Estimate of Costs Associated With Routine Preoperative Testing in Medicare Cataract Patients With a Procedure-Specific Indicator.
  16. Analysis of National Rates, Cost, and Sources of Cost Variation in Adult Spinal Deformity.
  17. Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.
  18. Analysis of Cost Variation in Craniotomy for Tumor Using 2 National Databases.
  19. Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans.
  20. Geographic and Hospital Variation in Cost of Lumbar Laminectomy and Lumbar Fusion for Degenerative Conditions.
  21. Repeated Critical Illness and Unplanned Readmissions Within 1 Year to PICUs.
  22. Trends in Utilization and Cost of Cervical Spine Surgery Using the National Inpatient Sample Database, 2001 to 2013.
  23. Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.
  24. Reconsidering Physician-Pharmaceutical Industry Relationships.
  25. Medicare Part D Plans' Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease.
  26. Association Between Surgeon Scorecard Use and Operating Room Costs.
  27. Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab.
  28. Important Distinctions Concerning Pharmaceutical Company-Sponsored Meals and Prescribing Patterns-Reply.
  29. Public Reporting of Hospital-Level Cancer Surgical Volumes in California: An Opportunity to Inform Decision Making and Improve Quality.
  30. Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized study.
  31. Guideline Update for Article on Pharmaceutical Industry-Sponsored Meals.
  32. Children and Young Adults Who Received Tracheostomies or Were Initiated on Long-Term Ventilation in PICUs.
  33. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
  34. Variation in Quality of Urgent Health Care Provided During Commercial Virtual Visits.
  35. Cost Analysis of the American Board of Internal Medicine's Maintenance-of-Certification Program. In response.
  36. Children and young adults who received tracheostomies or were initiated on long-term ventilation in pediatric ICUs
  37. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Patients
  38. From the closest observers of patient care: a thematic analysis of online narrative reviews of hospitals.
  39. Incorporating a New Technology While Doing No Harm, Virtually.
  40. How Financial and Reputational Incentives Can Be Used to Improve Medical Care.
  41. Calculations of Financial Incentives for Providers in a Pay-for-Performance Program: Manual Review Versus Data From Structured Fields in Electronic Health Records.
  42. Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection.
  43. A Cost Analysis of the American Board of Internal Medicine's Maintenance-of-Certification Program.
  44. Preoperative Testing in Patients Undergoing Cataract Surgery.
  45. Revisit rates and associated costs after an emergency department encounter: a multistate analysis.
  46. Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.
  47. Methods for Developing Patient-Reported Outcome-Based Performance Measures (PRO-PMs).
  48. Sources of traffic and visitors' preferences regarding online public reports of quality: web analytics and online survey results.
  49. Preoperative medical testing in Medicare patients undergoing cataract surgery.
  50. Efficient and sparse feature selection for biomedical text classification via the elastic net: Application to ICU risk stratification from nursing notes.
  51. Parents’ Experiences with Pediatric Care at Retail Clinics [commentary]
  52. Adults with childhood-onset chronic conditions admitted to US pediatric and adult intensive care units.
  53. Fighting the "oculostenotic reflex".
  54. Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation.
  55. Multidisciplinary Critical Care and Intensivist Staffing: Results of a Statewide Survey and Association With Mortality.
  56. N-gram support vector machines for scalable procedure and diagnosis classification, with applications to clinical free text data from the intensive care unit.
  57. Websites that offer care over the Internet: is there an access quality tradeoff?
  58. Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome.
  59. Physician payment incentives to improve care quality--reply.
  60. ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovas
  61. ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovas
  62. Adequacy of lymph node examination in colorectal surgery: contribution of the hospital versus the surgeon.
  63. Frequency, risk factors, and outcomes of early unplanned readmissions to PICUs.
  64. Small practices' experience with EHR, quality measurement, and incentives.
  65. Effect of pay-for-performance incentives on quality of care in small practices with electronic health records: a randomized trial.
  66. Effects of individual physician-level and practice-level financial incentives on hypertension care: a randomized trial.
  67. Measuring hospital quality using pediatric readmission and revisit rates.
  68. Regional variation in the incidence of dialysis-requiring AKI in the United States.
  69. Do hospitals that serve a high percentage of Medicaid patients perform well on evidence-based guidelines for colon cancer care?
  70. Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity?
  71. Dialysis facility profit status and compliance with a black box warning.
  72. Multi-institutional profile of adults admitted to pediatric intensive care units.
  73. Hospital-wide breastfeeding rates vs. breastmilk provision for very-low-birth-weight infants.
  74. Temporal changes in incidence of dialysis-requiring AKI.
  75. Perspectives on promoting breastmilk feedings for premature infants during a quality improvement project.
  76. The relationship between commercial website ratings and traditional hospital performance measures in the USA.
  77. Medicare's new hospital value-based purchasing program is likely to have only a small impact on hospital payments.
  78. Medicare immunosuppressant coverage and access to kidney transplantation: a retrospective national cohort study.
  79. Chronic conditions among children admitted to U.S. pediatric intensive care units: their prevalence and impact on risk for mortality and prolonged length of stay*.
  80. Factors associated with failure to screen newborns for retinopathy of prematurity.
  81. Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care.
  82. Functional status after colon cancer surgery in elderly nursing home residents.
  83. Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come.
  84. Major abdominal surgery in nursing home residents: a national study.
  85. Prediction of hospital acute myocardial infarction and heart failure 30-day mortality rates using publicly reported performance measures.
  86. Clinician perspectives on barriers to and opportunities for skin-to-skin contact for premature infants in neonatal intensive care units.
  87. Design, rationale, and baseline characteristics of a cluster randomized controlled trial of pay for performance for hypertension treatment: study protocol.
  88. The impact of statistical choices on neonatal intensive care unit quality ratings based on nosocomial infection rates.
  89. Antenatal steroid administration for premature neonates in California.
  90. The effect of race and ethnicity on outcomes among patients in the intensive care unit: a comprehensive study involving socioeconomic status and resuscitation preferences.
  91. Translating Evidence into Practice, Policy, and Public Health in Perinatal Medicine
  92. Users of Public Reports of Hospital Quality: Who, What, Why, and How?: An Aggregate Analysis of 16 Online Public Reporting Web Sites and Users’ and Experts’ Suggestions for Improvement, Rockville, MD: Agency for Healthcare Research and Quality
  93. Breastfeeding rates differ significantly by method used: a cause for concern for public health measurement.
  94. Correlates of depression among people with diabetes: The Translating Research Into Action for Diabetes (TRIAD) study.
  95. Patients' willingness to discuss trade-offs to lower their out-of-pocket drug costs.
  96. Predictors of early postdischarge mortality in critically ill patients: a retrospective cohort study from the California Intensive Care Outcomes project.
  97. Impact of changes in clinical practice guidelines on assessment of quality of care.
  98. Small numbers limit the use of the inpatient pediatric quality indicators for hospital comparison.
  99. An official American Thoracic Society policy statement: pay-for-performance in pulmonary, critical care, and sleep medicine.
  100. Cross-sectional analysis of hospitalist prevalence and quality of care in California.
  101. Health information technology and physicians' knowledge of drug costs.
  102. Health systems, patients factors, and quality of care for diabetes: a synthesis of findings from the TRIAD study.
  103. Characteristics of insured patients with persistent gaps in diabetes care services: the Translating Research into Action for Diabetes (TRIAD) study.
  104. Evaluating telemedicine in the ICU.
  105. Patient decision aids for prostate cancer treatment: a systematic review of the literature.
  106. Patient-centered care: what is the best measuring stick?
  107. Making the 'pay' matter in pay-for-performance: implications for payment strategies.
  108. Relationship between discharge practices and intensive care unit in-hospital mortality performance: evidence of a discharge bias.
  109. Investing time in health: do socioeconomically disadvantaged patients spend more or less extra time on diabetes self-care?
  110. Elderly patients' knowledge of drug benefit caps and communication with providers about exceeding caps.
  111. Mortality probability model III and simplified acute physiology score II: assessing their value in predicting length of stay and comparison to APACHE IV.
  112. Association between hospital-reported Leapfrog Safe Practices Scores and inpatient mortality.
  113. Performance measurement, public reporting, and pay-for-performance.
  114. Extreme makeover: Transformation of the veterans health care system.
  115. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention.
  116. Why physicians favor use of percutaneous coronary intervention to medical therapy: a focus group study.
  117. Can additional patient experience items improve the reliability of and add new domains to the CAHPS hospital survey?
  118. Quality of colon cancer outcomes in hospitals with a high percentage of Medicaid patients.
  119. Comparison of change in quality of care between safety-net and non-safety-net hospitals.
  120. United States rural hospital quality in the Hospital Compare database-accounting for hospital characteristics.
  121. Variation in ICU risk-adjusted mortality: impact of methods of assessment and potential confounders.
  122. Medicare's decision to withhold payment for hospital errors: the devil is in the det.
  123. Social Science Research Network
  124. Effects of hospital procedure volume and resident training on clinical outcomes and resource use in radical retropubic prostatectomy surgery in the Department of Veterans Affairs.
  125. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study.
  126. Elderly patients' preferences and experiences with providers in managing their drug costs.
  127. Agreement between self-reports and medical records was only fair in a cross-sectional study of performance of annual eye examinations among adults with diabetes in managed care.
  128. Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease.
  129. Overestimating outcome rates: statistical estimation when reliability is suboptimal.
  130. Pay-for-performance in pediatrics: proceed with caution.
  131. Identifying widely covered drugs and drug coverage variation among Medicare part D formularies.
  132. Quality of care in hospitals with a high percent of Medicaid patients.
  133. Pay-for-performance: will the latest payment trend improve care?
  134. Consumer Financial Incentives: A Decision Guide for Purchasers
  135. Public reporting and pay-for-performance: safety-net hospital executives' concerns and policy suggestions.
  136. The association between quality of care and the intensity of diabetes disease management programs.
  137. The relationship between health plan advertising and market incentives: evidence of risk-selective behavior.
  138. A behavioral model of clinician responses to incentives to improve quality.
  139. Development and validation of an index to predict activity of daily living dependence in community-dwelling elders.
  140. Pay for Performance: A Decision Guide for Purchasers
  141. Public reporting of provider performance: can its impact be made greater?
  142. Pay-for-performance research: how to learn what clinicians and policy makers need to know.
  143. Managing the unmanageable: the nature and impact of drug risk in physician groups.
  144. Independent medical review of health plan coverage denials: early trends.
  145. Assessing risk-adjustment approaches under non-random selection.
  146. Executive Summary: Strategies to Support Quality-based Purchasing: A Review of the Evidence
  147. Strategies to Support Quality-based Purchasing: A Review of the Evidence
  148. The Clinical and Economic Performance of Prepaid Group Practices
  149. Measuring quality in modern managed care.
  150. Volume as a surrogate for percutaneous coronary intervention quality: is this the right measuring stick?
  151. Aligning quality and payment for heart failure care: defining the challenges.
  152. Impact of surgeon and surgical center characteristics on choice of permanent vascular access.
  153. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care.
  154. Employers' efforts to measure and improve hospital quality: determinants of success.
  155. Exercise counseling practices among nephrologists caring for patients on dialysis.
  156. The best of both worlds? Potential of hybrid prospective/concurrent risk adjustment.
  157. The Translating Research Into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care.
  158. A Report Card Approach to ICUs
  159. Condition-Specific Patterns of Costly Illness: Implications for Risk Adjustment and Quality Monitoring
  160. Creating a Statewide Hospital Quality Reporting System. California Health Care Foundation: Oakland, CA
  161. Improving Health Care by Linking Risk Adjustment and Condition-Specific Quality Measurement
  162. Physician responses to evidence-based hospital referral programs.
  163. What's behind the health expenditure trends?
  164. Shared patient analysis: a method to assess the clinical benefits of patient referrals.
  165. Operator volume and clinical outcomes of primary coronary angioplasty for patients with acute myocardial infarction.
  166. Invited commentary: Physician responses to purchaser quality initiatives for surgical procedures.
  167. Managed care in transition.
  168. Treatment of unruptured cerebral aneurysms in California.
  169. Changes in births to foreign-born women after welfare and immigration policy reforms in California.
  170. Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery.
  171. Reconciling quality measurement with financial risk adjustment in health plans.
  172. Selective referral to high-volume hospitals: estimating potentially avoidable deaths.
  173. Assessing the relationship between quality of care and the characteristics of health care organizations.
  174. When and How Should Purchasers Seek to Selectively Refer Patients to High Quality Hospitals?
  175. Goals, targets, and tactics: making health care policy decisions explicit.
  176. Comparing the quality of care provided by health plans: are the data there?
  177. Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals.
  178. Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group.
  179. Methods to estimate and analyze medical care resource use. An example from liver transplantation.
  180. Population choice and variable selection in the estimation and application of risk models.
  181. Subspecialty care in radiology: oncologic imaging.
  182. Inconclusive clinical and ultrasound evaluation of the scrotum: impact of magnetic resonance imaging on patient management and cost.
  183. The impact of financial incentives on quality of health care.
  184. Fifth Seah Cheng Siang Memorial Lecture. Human immunodeficiency virus and the respiratory system--pulmonary manifestations of acquired immunodeficiency syndrome.
  185. Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery.
  186. Acute childbirth morbidity: its measurement using hospital charges.